Differentiating clinical trial endpoints in transthyretin cardiac amyloidosis is significantly improved with continuing medical education
17 May 2025 (08:00 - 12:45)
Organised by: 
About the speaker
Medscape Education Global, London (United Kingdom of Great Britain & Northern Ireland)
7 More presentations in this session
Doctor A. Pinho (Porto, PT)
Mr P. Kopp (Stony Brook, US)
Professor R. Sepp (Szeged, HU)
Access the full session
The Event
Heart Failure 2025
17 May - 20 May 2025
